Suchergebnisse - "Gurunthalingam, Meenalotchini Prakash"

PubPharm (7)

1

Vigilance Needed in Treating a Child with Disseminated TB : A Case Report

enthalten in: Infectious disorders drug targets | 2024

von Velmurugan, H. | Neelambaran, K. | Gurunthalingam, M. | +4

2

Hand Foot Syndrome Induced by Lenvatinib - A Case Report

enthalten in: Current drug safety | 2024

von Rangshahi, K. | Nanda, S. | Gurunthalingam, M. | +3

3

Prednisone and Live Birth Rate in Patients With Recurrent Implantation Failure

enthalten in: JAMA | 2023

von Gurunthalingam, M. | Katiyara, V. | Singh, M.

CommentOn: JAMA. 2023 May 2;329(17):1460-1468. - PMID 37129654

4

Can HCQ Be Considered a “Safe Weapon” for COVID-19 in the Indian Population?

enthalten in: SN comprehensive clinical medicine | 2020

von Thangaraju, P. | Venkatesan, N. | Venkatesan, S. | +2

5

Can HCQ Be Considered a “Safe Weapon” for COVID-19 in the Indian Population?

enthalten in: SN comprehensive clinical medicine | 2020

von Thangaraju, P. | Venkatesan, N. | Venkatesan, S. | +2

6

COVID-19 : Wait for a novel drug or act with the age old drug - Do we have a choice?

enthalten in: Journal of infection and public health | 2020

von Thangaraju, P. | Gurunthalingam, M. | Venkatesan, S. | +1

7

Can HCQ Be Considered a "Safe Weapon" for COVID-19 in the Indian Population?

enthalten in: SN comprehensive clinical medicine | 2020

von Thangaraju, P. | Venkatesan, N. | Venkatesan, S. | +2

1
[1]